Coronavirus Latest News
Oxford Covid vaccine has 10% efficacy against South African variant, study suggests
Small-scale trial of vaccine shows it offers very little protection against mild to moderate infection
The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested.
Scientists who conducted a small-scale trial of the vaccine’s efficacy said it showed very little protection against mild to moderate infection, though they expressed hope that – in theory – it would still offer significant protection against more serious infection.
Read the original article at The Guardian